KEMPHARM, INC Collaboration Agreements
3 Contracts & Agreements
- Amendment No. 1 to Collaboration and License Agreement, effective as of April 8, 2021, by and between the Company and Commave Therapeutics SA (Filed With SEC on August 13, 2021)
- Collaboration and License Agreement, dated as of September 3, 2019, by and between KemPharm, Inc. and Boston Pharmaceuticals Holdings SA (Filed With SEC on September 4, 2019)
- Collaboration and License Agreement by and between the Company and KVK Tech, Inc. dated as of October 25, 2018 (Filed With SEC on March 1, 2019)